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SUMMARY 
Galactosaemia is a rare metabolic disorder that presents in early infancy and affects 
multiple organs and systems and is potentially fatal if undetected early. We present 
a case of a seven week old male infant with jaundice from birth who presented with 
abdominal distension and feeding difficulties. He was ill looking at admission with 
moderate pallor, jaundice, hepatosplenomegaly and ascites. Investigations revealed 
anaemia, coagulopathy and deranged liver enzymes. A limited work up for cholestatic 
liver disease was suggestive of galactosaemia and the patient improved remarkably 
on institution of a galactose free diet. 
INTRODUCTION 
Galactosaemia is a rare autosomal recessive metabolic 
disorder affecting 1 in 30,000- 60,000 infants. Classic 
galactosaemia is caused by deficiency of the enzyme 
galactose-1- phosphate uridyl transferase (GALT) 
that prevents conversion of galactose to glucose (1). 
Most patients present in early infancy with jaundice, 
hepatosplenomegaly, hypoglycaemia, sepsis and 
cataracts. Hepatocellular insufficiency and acute liver 
failure are known but unusual presentations (2). There 
are no reports in the literature of infants presenting 
with acute liver failure in Africa. We present a case 
of a seven week old infant who  presented with 
acute hepatocellular insufficiency and noted to have 
galactosaemia on investigations and who made a good 
recovery after eliminating galactose from his diet. 
CASE REPORT 
A seven week old male infant of Somali ethnicity was 
referred by a general physician with history of jaundice 
since birth and abdominal swelling for a few days. 
Jaundice was noticed from the first day of life and was 
progressively getting worse, with dark yellow urine but 
pigmented (light yellow) stool. He had been feeding 
well, on both breast milk and formula milk (Nan) until 
a few days earlier when he started tiring during feeds 
but without sweating or cyanosis. He was also described 
as being lethargic during the preceding 72 hours. No 
bleeding tendencies or rashes were reported although 
he did have an occasional low-grade fever. 
 The infant had been born at term by emergency 
Caesarean section secondary to cephalopelvic 
disproportion to a 26-year-old mother who had two 
previous first trimester pregnancy wastages. There 
was no history of liver disease or consanguineous 
marriages in the family. 
 Examination revealed a sick infant who was 
wasted, had moderate to severe pallor and moderate 
scleral icterus, was afebrile with mild pedal oedema 
but without any obvious dysmorphic features. He had 
a heart rate of 141 beats per minute and a respiratory 
rate of 42 breaths per minute. He was sleepy but 
rousable with mild hypotonia. The abdomen was 
asymmetrically distended more at the flanks with a 
girth of 38 cm at the umbilicus. 
 The liver was enlarged to 3 cm below the costal 
margin along the mid-clavicular line, he had a tipped 
spleen and there was moderate ascites. There were 
no petechial lesions or mucosal bleeds. The rest of 
the examination was normal. 
 His initial tests revealed a haemoglobin level 
of 7.8 grams/liter, white cell count of 15,000/mm3, 
platelets of 326,000/mm3 and a random blood sugar 
of 2.85 mmol/liter. Both mother and infant were 
blood group B+. The bilirubin and aspartate amino 
transferase (AST) levels were elevated and his initial 
international normalising ratio (INR) was 2.0 with a 
prothrombin time index (PTI) of 28% (Table 1). 
 An abdominal scan showed a hyperechogenic 
liver, non-dilated intrahepatic ducts, and oedematous 
walls of the gall bladder. Serology for VDRL, HIV, 
hepatitis B and C and IgM for cytomegalovirus was 
negative. Blood and urine cultures were sterile. 
 A limited work-up for prolonged cholestatic 
jaundice was done (Table 2). The most significant 
was a positive test for urine reducing substances 
(twice). A confirmatory test of reduced galactose-1-
phosphate uridyl transferase (GALT) enzyme activity 
done at a referral laboratory confirmed the diagnosis 
of galactosaemia. 
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Table 1
Baseline and in-patient follow up investigations
Test  Day 1  Day 6  Day 9 
Total Bilirubin (mmol/L)  147  37  44 
Direct Bilirubin (mmol/L)  87  32  17 
AST (U/L)  108  94  66 
ALT(U/L)  38  37  49 
ALP (U/L)  772  495  220 
Albumin (g/L)  26.1  34  32 
PTI (%)  28  52  98 
INR  2.08  1.6  1.0 
Random Blood Sugar  2.85  4.0  3.8 
Ammonia  932   
Creatinine (mmol/L)  21 
  
Table 2 
Distinguishing and confirmatory tests 
Test  Result  Normal values 
Urine glucose  Negative  
Urine reducing substances  Positive (twice)  
Alpha-I-antitrypsin  1.32  0.88 - 1.74 
Transferrin  <0.70  2.0 - 3.2 
Ferritin  466  200 - 500 
Thyroid function  Normal 
Galactose 1 PUT  10.9  15.1 - 34.3 
The patient was commenced on intravenous 
fluids (dextrose saline), broad spectrum antibiotics 
(cefotaxime and amikacin) and diuretics 
(spironolactone). The patient had a stormy clinical 
course during the first 48 hours requiring admission 
to the intensive care unit for progressive respiratory 
distress needing therapeutic paracentesis as well as 
multiple blood transfusions. He was started on a 
lactose-free diet once the urine reducing substance 
result was known and gradually made a good 
recovery. His abdominal girth progressively reduced 
and was discharged after eleven days on a lactose-
free soy formula. 
 The patient was later evaluated by an 
ophthalmologist and noted to have mild lens 
displacement  but no cataracts.  At 12 months of 
age, the patient had achieved all his major motor 
milestones, is now walking and making babbling 
sounds and has appropriate weight gain on a lactose-
free (soy) formula. 
DISCUSSION 
Fulminant liver failure is defined as a multisystemic 
disorder in which severe impairment of liver function, 
with or without encephalopathy, occurs in association 
with hepatocellular necrosis in a patient with no 
recognisable underlying chronic liver disease (3). 
Liver failure is a rare presenting feature in the neonatal 
period and potential aetiologies include inborn errors 
of metabolism, infections, ischaemia and abnormal 
perfusion (4). Common metabolic causes include 
galactosaemia, fructosaemia, tyrosinaemia type 1 
and bile acid synthesis defects (1, 2). Galactosaemia 
is the most common of these metabolic diseases in 
South Africa with an estimated incidence of 1 in 
14,400 that is much higher than that reported in 
developed countries (5). Fateen et al (6) in Egypt 
showed that galactosaemia was present in 7% high 
risk neonates (jaundice, hepatomegaly and failure to 
thrive) compared to 0.05% amongst normal neonates. 
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The high rate of galactosaemia in South Africa and 
Egyptian neonates suggests that the scarcity of 
reports on this problem from Africa may be due to 
underreporting related to low levels of ascertainment. 
Lack of knowledge on this condition, low index 
of suspicion among clinicians, unavailability of 
diagnostic tests and the large burden of infectious 
diseases that present similar to galactosaemia may 
further complicate the ascertainment of cases. 
 Common clinical presentation of galactosaemia 
includes feeding difficulties, vomiting, cataracts, 
prolonged jaundice and failure to thrive. Jaundice 
is a more common presenting feature present in 77 - 
100% in reported case series but liver failure has been 
infrequently documented as well (6, 7). Our infant had 
severe acute liver failure on presentation as evidenced 
by severe coagulopathy (INR of 2.0). There have been 
no reports from Africa on infants with galactosaemia 
presenting with acute hepatocellular dysfunction. 
In one case report of galactosaemia presenting at 11 
months of age, the infant had persistent jaundice and 
no evidence of hepatocellular failure (8). 
 Correctly identifying the disease may be life-
saving as treatment simply involves instituting a 
lactose free diet although there has been a report of 
blood exchange transfusion as a treatment option 
in the past (9). Our patient presented early with 
liver failure and underwent standard conservative 
management for liver failure but made a quick 
recovery once he was put on a lactose-free diet. He 
has had a complete recovery with normal synthetic 
function since discharge from hospital. 
 Other complications of galactosaemia include 
cataracts and neurological deficits (2). The seven 
week old infant was reviewed by an ophthalmologist 
and noted to have early cataract and is on regular 
follow up. The patient has also had normal neuro-
developmental milestones so far and can now walk at 
12 months. However, it is known that most children 
with galactosaemia, including those detected early 
by newborn screening methods do have some form 
of neurodevelopmental delay (2). 
 Nutritional counselling and appropriate 
advice plays an important role in the management 
of galactosaemia. Traces of lactose are found in 
several food substitutes and there is evidence that 
there is endogenous galactose production within 
the human body, which are thought to contribute to 
later complications of the disease (10). A recent study 
showed that an elemental diet may be more effective 
at controlling GALT1 levels (11). Our patient has done 
relatively well on a soy-based formula although we 
have not repeated his GALT1 assay. Unfortunately he 
has only seen the dietitian once since discharge but 
the parents have been diligent in avoiding lactose-
containing foods. The exact duration of lactose free 
diet is not known although most experts agree that 
galactose should be restricted for life (2). 
In conclusion, our report contributes to the limited data 
on galactosaemia in Africa, presenting as acute liver 
failure in an infant. Since routine neonatal screening 
is not done in Africa, screening for galactosaemia 
in high risk patients such as those with prolonged 
jaundice, hepatomegaly and failure to thrive may 
help diagnose this otherwise fatal disorder. 
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